Clinical Trial Update: Phase II Efficacy Study of AZD6244 in Colorectal Cancer [Phase 2]

View source ↗

Summary

This report covers the completion of a Phase II efficacy study of AZD6244 in metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Selumetinib (selumetinib)

Snippet

Sponsor: AstraZeneca | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED